Current situation and risk factors for Helicobacter pylori eradication failure in Northwest China: a real-world evidence study

Chin Med J (Engl). 2023 Feb 20;136(4):488-490. doi: 10.1097/CM9.0000000000002557.

Authors

Xiaojing Zhu¹, Songbo Li¹, Yuan Liu², Lifeng Zhang¹, Wei Lu³, Yongquan Shi¹

Affiliations

¹ State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.
² Department of Emergency, Xin'an Central Hospital, Xi'an, Shaanxi 710048, China.
³ Department of Gastroenterology, Xi'an No.1 Hospital, Xi'an, Shaanxi 710002, China.

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / therapeutic use
China / epidemiology
Drug Therapy, Combination
Helicobacter Infections* / drug therapy
Helicobacter pylori*
Humans
Proton Pump Inhibitors / therapeutic use
Risk Factors

Substances

Anti-Bacterial Agents
Proton Pump Inhibitors